loadpatents
name:-0.027034997940063
name:-0.019392013549805
name:-0.0027780532836914
Ermann; Monika Patent Filings

Ermann; Monika

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ermann; Monika.The latest application filed is for "compounds for treatment of diseases related to dux4 expression".

Company Profile
3.26.25
  • Ermann; Monika - Abingdon GB
  • Ermann; Monika - Oxfordshire GB
  • Ermann; Monika - Wantage N/A GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compounds for treatment of diseases related to DUX4 expression
App 20220226318 - De Maeyer; Joris ;   et al.
2022-07-21
Compounds for treatment of diseases related to DUX4 expression
App 20210177847 - De Maeyer; Joris ;   et al.
2021-06-17
Compounds for treatment of diseases related to DUX4 expression
Grant 10,973,820 - de Maeyer , et al. April 13, 2
2021-04-13
Bicyclic tetrahydrothiazepine derivatives useful for the treatment of neoplastic and/or infectious diseases
Grant 10,472,341 - Ermann , et al. Nov
2019-11-12
Compounds for treatment of diseases related to DUX4 expression
App 20190175596 - de Maeyer; Joris ;   et al.
2019-06-13
Bicyclic Tetrahydrothiazepine Derivatives Useful For The Treatment Of Neoplastic And/or Infectious Diseases
App 20180170888 - ERMANN; Monika ;   et al.
2018-06-21
Deubiquitinase inhibitors and methods for use of the same
Grant 9,868,736 - Donato , et al. January 16, 2
2018-01-16
Deubiquitinase Inhibitors And Methods For Use Of The Same
App 20160237082 - Donato; Nicholas J. ;   et al.
2016-08-18
Compounds which modulate the CB2 receptor
Grant 9,315,454 - Bartolozzi , et al. April 19, 2
2016-04-19
Amine and ether compounds which modulate the CB2 receptor
Grant 8,957,063 - Cirillo , et al. February 17, 2
2015-02-17
Sulfonyl compounds which modulate the CB2 receptor
Grant 8,846,936 - Hickey , et al. September 30, 2
2014-09-30
Compounds which modulate the CB2 receptor
Grant 8,829,034 - Berry , et al. September 9, 2
2014-09-09
Compounds which selectively modulate the CB2 receptor
Grant 8,735,430 - Bartolozzi , et al. May 27, 2
2014-05-27
Sulfonyl Compounds Which Modulate The Cb2 Receptor
App 20130184315 - Hickey; Eugene Richard ;   et al.
2013-07-18
Compounds which selectively modulate the CB2 receptor
Grant 8,383,651 - Bartolozzi , et al. February 26, 2
2013-02-26
Compounds which selectively modulate the CB2 receptor
Grant 8,372,874 - Bartolozzi , et al. February 12, 2
2013-02-12
Compounds Which Selectively Modulate The CB2 Receptor
App 20130030022 - BARTOLOZZI; Alessandra ;   et al.
2013-01-31
Therapeutic uses of compounds which selectively modulate the CB2 receptor
Grant 8,362,039 - Bartolozzi , et al. January 29, 2
2013-01-29
Therapeutic uses of compounds which selectively modulate the CB2 receptor
Grant 8,349,871 - Bartolozzi , et al. January 8, 2
2013-01-08
Compounds Which Modulate The Cb2 Receptor
App 20120316173 - Bartolozzi; Alessandra ;   et al.
2012-12-13
Tetrazole compounds which selectively modulate the CB2 receptor
Grant 8,329,735 - Ermann , et al. December 11, 2
2012-12-11
Compounds which modulate the CB2 receptor
Grant 8,299,111 - Berry , et al. October 30, 2
2012-10-30
Tetrazole Compounds Which Selectively Modulate The CB2 Receptor
App 20120071529 - ERMANN; Monika ;   et al.
2012-03-22
Sulfone Compounds Which Modulate The CB2 Receptor
App 20120015988 - Hickey; Eugene Richard ;   et al.
2012-01-19
Therapeutic Uses of Compounds Which Selectively Modulate The CB2 Receptor
App 20120010184 - BARTOLOZZI; Alessandra ;   et al.
2012-01-12
Therapeutic Uses of Compounds Which Selectively Modulate The CB2 Receptor
App 20110312932 - BARTOLOZZI; Alessandra ;   et al.
2011-12-22
Compounds which selectively modulate the CB2 receptor
Grant 8,048,899 - Bartolozzi , et al. November 1, 2
2011-11-01
Amine and Ether Compounds Which Modulate The CB2 Receptor
App 20110190256 - Cirillo; Pier Francesco ;   et al.
2011-08-04
Compounds Which Selectively Modulate The CB2 Receptor
App 20110136869 - Bartolozzi; Alessandra ;   et al.
2011-06-09
Compounds Which Modulate The CB2 Receptor
App 20110130431 - BERRY; Angela ;   et al.
2011-06-02
Compounds which modulate the CB2 receptor
Grant 7,935,715 - Berry , et al. May 3, 2
2011-05-03
Compounds which modulate the CB2 receptor
Grant 7,928,123 - Berry , et al. April 19, 2
2011-04-19
Compounds Which Modulate the CB2 Receptor
App 20110071127 - BERRY; Angela ;   et al.
2011-03-24
Compounds Which Selectively Modulate The CB2 Receptor
App 20110071196 - BARTOLOZZI; Alessandra ;   et al.
2011-03-24
Diazepane Compounds Which Modulate The CB2 Receptor
App 20100261708 - Cirillo; Pier Francesco ;   et al.
2010-10-14
Compounds Which Selectively Modulate The CB2 Receptor
App 20100081644 - BARTOLOZZI; Alessandra ;   et al.
2010-04-01
Compounds Which Selectively Modulate The CB2 Receptor
App 20100076029 - BARTOLOZZI; Alessandra ;   et al.
2010-03-25
Compounds which modulate the CB2 receptor
Grant 7,595,397 - Zindell , et al. September 29, 2
2009-09-29
Compounds which Modulate the CB2 Receptor
App 20080081822 - Berry; Angela ;   et al.
2008-04-03
Compounds Which Modulate The CB2 Receptor
App 20080039464 - BERRY; Angela ;   et al.
2008-02-14
Compounds Which Modulate The CB2 Receptor
App 20070191340 - Zindell; Renee ;   et al.
2007-08-16
Substituted heterocyclic compounds and methods of use
App 20050070554 - Nunes, Joseph J. ;   et al.
2005-03-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed